Gallic acid attenuates diabetic cardiomyopathy by inhibiting ferroptosis and protecting mitochondria via the TSPO/FTMT pathway

PurposeDiabetic cardiomyopathy (DCM), which is diabetes mellitus-induced cardiomyopathy, significantly elevates the risk of heart failure and sudden cardiac death. No specific treatments for DCM are currently available. Gallic acid (GA) is a polyhydroxyphenolic compound that has been shown to inhibi...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Chenchao Zou, Huaihan Xu, Fajia Hu, Yuxian Yu, Lanxiang Liu, Xiuqi Wang, Zheyu Zhang, Huaxi Zou, Jichun Liu, Huang Huang, Songqing Lai
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-12-01
Saila:	Frontiers in Pharmacology
Gaiak:	phytochemical diabetic cardiomyopathy mitochondrial homeostasis ferroptosis reactive oxygen species
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1661144/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!